Related Experiment Video
Updated: Jul 12, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Prevalence of pericardial effusion in autosomal dominant polycystic kidney disease
Johanna Sophia Jost1, Till Frederik Kaireit2, Bernd Auber3
1Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Insights
Pericardial effusion (PE) affects 6.3% of autosomal dominant polycystic kidney disease (ADPKD) patients, with higher prevalence in females. Autoimmune diseases were more common in patients with PE, suggesting further investigation for non-ADPKD pathologies.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is associated with various extrarenal manifestations.
- Pericardial effusion (PE) is a potential underrecognized complication of ADPKD, with reported prevalence up to 35%.
Purpose of the Study:
- To systematically evaluate the prevalence of PE in an ADPKD cohort outside the USA.
- To identify associated risk factors for PE in ADPKD patients.
Main Methods:
- Retrospective analysis of clinically stable ADPKD patients from a specialized outpatient clinic.
- Evaluation of computed tomography (CT) and magnetic resonance imaging (MRI) scans for PE presence (≥4 mm).
- Correlation of imaging findings with clinical characteristics.
Main Results:
- Pericardial effusion (PE) was detected in 17 out of 208 evaluable ADPKD patients (8.2%), resulting in an overall prevalence of 6.3%.
- PE prevalence was higher in females (7.8%) compared to males (3.8%).
- Autoimmune diseases were more prevalent in patients with PE (11.8% vs. 2.1%, P=.022); no association was found with rapid disease progression, ADPKD genotype, age, or BMI.
Conclusions:
- The prevalence of PE in this ADPKD cohort was lower than previously reported, with a notable female predominance.
- Further attention to patients with PE >10 mm is warranted due to potential co-existing non-ADPKD pathologies.
- Renal functional impairment, sex, and proteinuria are suggested as candidate variables for further investigation.
Background:
Autosomal dominant polycystic kidney disease (ADPKD) has numerous extrarenal manifestations. Pericardial effusion (PE) may be an underrecognized complication with a reported prevalence of up to 35%. Our study is the first to systematically evaluate the prevalence of PE and associated risk factors in an ADPKD cohort outside the USA.
Methods:
Clinically stable ADPKD patients from a specialized outpatient clinic were evaluated retrospectively. Magnetic resonance tomography and computed tomography scans were analysed regarding the presence of PE (≥4 mm). Imaging results were linked to clinical characteristics.
Results:
Of 286 ADPKD patients, 208 had computed tomography or magnetic resonance imaging suitable for evaluation of PE. In this group we detected PE in 17 patients (8.2%). The overall prevalence of PE was 6.3%, with more females being affected (prevalence of PE was 7.8% in females and 3.8% in males). The PE mean size was 6.8 ± 3.3 mm. The prevalence of autoimmune diseases was higher in the patients with PE (11.8% versus 2.1%, P = .022), while the presence and size of PE was not associated with signs of rapid progressive disease, ADPKD genotype, patient age, body mass index and other clinical parameters. Exploratory investigation of individual characteristics of PE patients by regression tree analysis suggested renal functional impairment, sex and proteinuria as candidate variables.
Conclusions:
PE prevalence in our cohort was lower than previously reported and showed a clear female preponderance. Our data suggest that patients with PEs >10 mm deserve further attention, as they may have additional non-ADPKD-related pathologies.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Pericarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Chronic Kidney Disease II: Clinical Manifestations
Pericarditis II: Clinical Features and Diagnostic Tests

